{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:10:16Z","timestamp":1778836216446,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["111\\u20132314-B-002\\u2013267 -"],"award-info":[{"award-number":["111\\u20132314-B-002\\u2013267 -"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW109-TDU-B-211\\u2013134009"],"award-info":[{"award-number":["MOHW109-TDU-B-211\\u2013134009"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW107-TDU-B-211\\u2013114009"],"award-info":[{"award-number":["MOHW107-TDU-B-211\\u2013114009"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW108-TDU-B-211\\u2013124009"],"award-info":[{"award-number":["MOHW108-TDU-B-211\\u2013124009"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.tranon.2025.102449","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T04:51:16Z","timestamp":1750913476000},"page":"102449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PHF6 and RUNX1 mutations cooperate to accelerate leukemogenesis"],"prefix":"10.1016","volume":"59","author":[{"given":"Yueh-Chwen","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5052-9445","authenticated-orcid":false,"given":"Chi-Yuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Tsu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Chin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-An","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chein-Jun","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7447-8045","authenticated-orcid":false,"given":"Chia-Lang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2967-698X","authenticated-orcid":false,"given":"Wen-Chien","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwei-Fang","family":"Tien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.tranon.2025.102449_bib0001","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1182\/bloodadvances.2019000391","article-title":"Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials","volume":"3","author":"Hsu","year":"2019","journal-title":"Blood Adv."},{"issue":"23","key":"10.1016\/j.tranon.2025.102449_bib0002","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1182\/blood.2019000468","article-title":"The chromatin-binding protein Phf6 restricts the self-renewal of hematopoietic stem cells","volume":"133","author":"Miyagi","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.tranon.2025.102449_bib0003","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1158\/2159-8290.CD-18-1005","article-title":"Phf6 loss enhances HSC self-renewal driving tumor initiation and leukemia stem cell activity in T-ALL","volume":"9","author":"Wendorff","year":"2019","journal-title":"Cancer Discov."},{"issue":"16","key":"10.1016\/j.tranon.2025.102449_bib0004","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood-2018-07-860726","article-title":"PHF6 regulates hematopoietic stem and progenitor cells and its loss synergizes with expression of TLX3 to cause leukemia","volume":"133","author":"McRae","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.tranon.2025.102449_bib0005","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41375-021-01392-1","article-title":"PHF6 and JAK3 mutations cooperate to drive T-cell acute lymphoblastic leukemia progression","volume":"36","author":"Yuan","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.tranon.2025.102449_bib0006","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/leu.2010.247","article-title":"PHF6 mutations in adult acute myeloid leukemia","volume":"25","author":"Van Vlierberghe","year":"2011","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.tranon.2025.102449_bib0007","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/cam4.5173","article-title":"PHF6 mutation is associated with poor outcome in acute myeloid leukaemia","volume":"12","author":"Huang","year":"2023","journal-title":"Cancer Med."},{"issue":"5","key":"10.1016\/j.tranon.2025.102449_bib0008","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1101\/gad.254151.114","article-title":"A genome-scale in vivo loss-of-function screen identifies Phf6 as a lineage-specific regulator of leukemia cell growth","volume":"29","author":"Meacham","year":"2015","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.tranon.2025.102449_bib0009","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood-2013-01-480244","article-title":"Runx1 is essential at two stages of early murine B-cell development","volume":"122","author":"Niebuhr","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.tranon.2025.102449_bib0010","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s12185-013-1347-3","article-title":"A role for RUNX1 in hematopoiesis and myeloid leukemia","volume":"97","author":"Ichikawa","year":"2013","journal-title":"Int. J. Hematol."},{"issue":"11","key":"10.1016\/j.tranon.2025.102449_bib0011","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.tranon.2025.102449_bib0012","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.tranon.2025.102449_bib0013","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1038\/leu.2016.212","article-title":"Somatic PHF6 mutations in 1760 cases with various myeloid neoplasms","volume":"30","author":"Mori","year":"2016","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.tranon.2025.102449_bib0014","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/s41467-024-46134-w","article-title":"Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting","volume":"15","author":"Kubota","year":"2024","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.tranon.2025.102449_bib0015","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/leu.2016.126","article-title":"RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features","volume":"30","author":"Gaidzik","year":"2016","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.tranon.2025.102449_bib0016","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.tranon.2025.102449_bib0017","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/immu.200310005","article-title":"Transgenic mice with hematopoietic and lymphoid specific expression of Cre","volume":"33","author":"Jd","year":"2003","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.tranon.2025.102449_bib0018","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1182\/blood-2007-01-068346","article-title":"AML1 mutations induced MDS and MDS\/AML in a mouse BMT model","volume":"111","author":"Watanabe-Okochi","year":"2008","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.tranon.2025.102449_bib0019","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1158\/0008-5472.CAN-13-1616","article-title":"Integrative radiogenomic profiling of squamous cell lung cancer","volume":"73","author":"Abazeed","year":"2013","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.tranon.2025.102449_bib0020","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1038\/bcj.2014.46","article-title":"Human HMGA2 protein overexpressed in mice induces precursor T-cell lymphoblastic leukemia","volume":"4","author":"Efanov","year":"2014","journal-title":"Blood Cancer J."},{"issue":"15","key":"10.1016\/j.tranon.2025.102449_bib0021","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1182\/bloodadvances.2017004457","article-title":"Hmga2 collaborates with JAK2V617F in the development of myeloproliferative neoplasms","volume":"1","author":"Ueda","year":"2017","journal-title":"Blood Adv."},{"issue":"14","key":"10.1016\/j.tranon.2025.102449_bib0022","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1182\/blood-2014-02-554543","article-title":"Hmga2 is a direct target gene of RUNX1 and regulates expansion of myeloid progenitors in mice","volume":"124","author":"Lam","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.tranon.2025.102449_bib0023","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1182\/bloodadvances.2018024422","article-title":"RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs","volume":"3","author":"Gerritsen","year":"2019","journal-title":"Blood Adv."},{"issue":"20","key":"10.1016\/j.tranon.2025.102449_bib0024","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1182\/blood-2017-03-774653","article-title":"H3(K27M\/I) mutations promote context-dependent transformation in acute myeloid leukemia with RUNX1 alterations","volume":"130","author":"Lehnertz","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.tranon.2025.102449_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/jdb9040044","article-title":"MEIS1 in hematopoiesis and cancer. How MEIS1-PBX interaction can be used in therapy","volume":"9","author":"Blasi","year":"2021","journal-title":"J. Dev. Biol."},{"issue":"2","key":"10.1016\/j.tranon.2025.102449_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087646","article-title":"Homeodomain transcription factor meis1 is a critical regulator of adult bone marrow hematopoiesis","volume":"9","author":"Ariki","year":"2014","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.tranon.2025.102449_bib0027","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00277-016-2913-6","article-title":"Meis1 is critical to the maintenance of human acute myeloid leukemia cells independent of MLL rearrangements","volume":"96","author":"Liu","year":"2017","journal-title":"Ann. Hematol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102449_bib0028","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1182\/bloodadvances.2022007015","article-title":"Npm1 haploinsufficiency in collaboration with MEIS1 is sufficient to induce AML in mice","volume":"7","author":"Muranyi","year":"2023","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.tranon.2025.102449_bib0029","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/s41375-018-0375-7","article-title":"LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML","volume":"33","author":"Barth","year":"2019","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.tranon.2025.102449_bib0030","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.leukres.2015.06.005","article-title":"Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients","volume":"39","author":"Chen","year":"2015","journal-title":"Leuk. Res."},{"issue":"23","key":"10.1016\/j.tranon.2025.102449_bib0031","doi-asserted-by":"crossref","first-page":"14925","DOI":"10.1073\/pnas.222491799","article-title":"Expression profiling of CD34+ hematopoietic stem\/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia","volume":"99","author":"Qian","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"24","key":"10.1016\/j.tranon.2025.102449_bib0032","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.7150\/jca.33244","article-title":"High expression of DOCK2 indicates good prognosis in acute myeloid leukemia","volume":"10","author":"Hu","year":"2019","journal-title":"J. Cancer"},{"issue":"3","key":"10.1016\/j.tranon.2025.102449_bib0033","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/leu.2016.284","article-title":"DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells","volume":"31","author":"Wu","year":"2017","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.tranon.2025.102449_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111568","article-title":"ELMO1 is upregulated in AML CD34+ stem\/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AML","volume":"9","author":"Capala","year":"2014","journal-title":"PLoS. One"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325001809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325001809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:30:56Z","timestamp":1778833856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325001809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":34,"alternative-id":["S1936523325001809"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102449","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PHF6 and RUNX1 mutations cooperate to accelerate leukemogenesis","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102449"}}